Medical Collagen Market Analysis, Size, and Share by 2028

The medical collagen market is expected to reach US$ 957.4 million by 2028 from US$ 593.7 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.

Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is a biocompatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. It is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. The growth of the medical collagen market is attributed to the factors such as the rising applications of collagen in the medical industry, and growing FDA approvals and product launches. However, product recalls hinder the market growth.

Medical Collagen Market: Strategic Insights

Market Insights

Rising Applications of Collagen in Medical Industry

Collagen is the protein found in connective tissues of the body. It is the most abundant protein found in the mammals, which makes up around 25%–35% of the whole-body protein content. As collagen is weakly antigenic and biodegradable, it has excellent biocompatibility. Thus, making it a primary resource in medical applications.

The cardiac extracellular matrix (ECM) consists of fibrillar collagen that provides a means of force transmission, preserves myocardial integrity, and supports myocyte geometry. Several studies have proved that consuming collagen supplements will help in reducing the risk of heart-related conditions.

Collagen is one of the key constituents in cosmetic formulations as it has moisturizing, regenerating, and film-forming properties. Collagen has excellent ability to bind water that helps in maintaining proper water content in the skin throughout the day, which makes the skin moisturized and softened. Moreover, collagen fillers are widely used in aesthetic medicine. The subcutaneous injection of soluble collagen enhances the quality and density of the skin, thereby repairing its dermatological defects.

Collagen-based biomaterials have a wide range of applications in vivo and in vitro. Collagen has been widely used to develop synthetic bone graft substitutes of spine, extremities, and dental. Further, collagen scaffolds are developed to mimic and regenerate native tissues and are being rapidly adopted for cartilage repair.

Collagen is naturally involved in the wound-healing process and the use of collagen-based wound dressings offers several advantages for acute and chronic wound closure. Additionally, collagen dressings can control the moisture of the wound, by either absorbing or providing moisture. Thus, collagen is widely used in dressings, particles, and flowable scaffolds to treat acute and chronic wounds.

These wide range of applications of collagen in the medical industry favors the growth of the market.

Product-based Insights

Product-based Insights

Based on product, the medical collagen market is segmented into gelatine, hydrolysed collagen, native collagen, and others. The gelatine segment held the largest market share in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.

Application-based Insights

Based on application, the medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other. The wound care segment held the largest market share in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the medical collagen market players to enlarge customer base worldwide, which, in turn, permits them to maintain their brand name globally.

Medical Collagen Market Players Density: Understanding Its Impact on Business Dynamics

The Medical Collagen Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Medical Collagen Market – by Source

• Bovine
• Porcine
• Others

Medical Collagen Market – by Product

• Gelatine
• Hydrolysed Collagen
• Native Collagen
• Others

Medical Collagen Market – by Application

• Wound Care
• Bone Grafts
• Tissue Scaffolds
• Cartilage Repair
• Haemostats
• Diagnostics
• Vascular Grafts
• Other

Medical Collagen Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
• South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

• DSM
• Integra Lifesciences Corporation
• Collagen Matrix Inc.
• Encoll
• Collagen Solutions Plc
• Innocoll
• Symatese
• Gelita AG
• Collplant Biotechnologies Ltd
• Croda Interntional PLC.